Case details

Print
Merger control
Case reference
Ccent/2021/59 - Grupo Triton / Grupo Clinigen
Acquirer
Triley Bidco Limited
Description
It is a company indirectly controlled by Triton Fund V, Jersey, a private equity firm that manages a multiplicity of funds and independent investment companies.
Target
Clinigen Group plc
Description
It is a pharmaceutical services and products company, which focuses its activity on providing access to its own medicines and third-party medicines in order to respond to unmet medical needs and/or for use in clinical trials.
Sector
Extractive and manufacturing Industries
Activity (NACE)
Manufacture of basic pharmaceutical products
Applicable legislation
Art. 37(1)(c) (Law 19)
Notification thresholds
Turnover threshold
Type of merger
Conglomerate
Cooperation with sector regulators
Status
Closed
Type of Investigation
Phase 1
AdC’s decision
Non-opposition
Case description
The notified concentration consists of the acquisition of sole control over Clinigen Group by Triley Bidco.
Timeline
Click here to see your activities